Narus Financial Partners, LLC

Position in AMGN — Amgen Inc

CIK 1698091 SALT LAKE CITY, UT

Position in AMGN

as of Jun 30, 2026 · filed Jul 31, 2026 Compact

Position Value

$232,118

-$2,214 QoQ

Shares Held

641

-3.8% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.10%

of 13F equity value

Holder Rank

#2,750

of 3,140 holders

Holding Since

Mar 2021

11 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Narus Financial Partners, LLC holds $2,295,659 across 6 Drug Manufacturers - General names. AMGN ranks #6 (10.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABBV	AbbVie Inc.	2,388	$600,916
2	LLY	ELI LILLY & Co	437	$524,150
3	BMY	Bristol Myers Squibb Co	6,636	$382,366
4	NVS	Novartis AG	1,889	$296,044
5	JNJ	Johnson & Johnson	1,024	$260,065
6	AMGN	Amgen Inc This page	641	$232,118

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$232,118	641	-3.8%	Shares	Sole	2026-07-31
2026-03-31	$234,332	666	0.0%	Shares	Sole	2026-04-21
2025-12-31	$217,988	666	-7.0%	Shares	Sole	2026-02-09
2025-03-31	$223,069	716	0.0%	Shares	Sole	2025-04-30
2024-09-30	$230,702	716	0.0%	Shares	Sole	2024-10-18
2024-06-30	$223,714	716	0.0%	Shares	Sole	2024-07-17
2024-03-31	$203,573	716	0.0%	Shares	Sole	2024-04-18
2023-12-31	$206,222	716	-7.7%	Shares	Sole	2024-01-25
2023-09-30	$208,557	776	-2.1%	Shares	Sole	2023-10-30
2022-12-31	$208,273	793	-7.8%	Shares	Sole	2023-10-12
2021-03-31	$213,976	860	—	Shares	Sole	2024-03-07
No filing history on record for this holder in this stock.